Ledger.Open graph →
SEC Form D · filed February 1, 2021

Mercy BioAnalytics, Inc

Offering
$27.3M
Sold
$27.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NATICK, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Paul Blavin · Natick, MAExec · DirectorJoseph Sedlak · Natick, MAExec · DirectorStanley Lapidus · Arlington, MADirectorPaul Meister · Seattle, WADirectorSonja H. Perkins · San Francisco, CADirectorPaul Blavin · Natick, MAExec · DirectorJoseph Sedlak · Natick, MAExec · DirectorStanley Lapidus · LEXINGTON, MADirectorPaul Meister · High Point, NCDirectorSonja H. Perkins · Natick, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗